EP1545608A4 - Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations - Google Patents
Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisationsInfo
- Publication number
- EP1545608A4 EP1545608A4 EP03742272A EP03742272A EP1545608A4 EP 1545608 A4 EP1545608 A4 EP 1545608A4 EP 03742272 A EP03742272 A EP 03742272A EP 03742272 A EP03742272 A EP 03742272A EP 1545608 A4 EP1545608 A4 EP 1545608A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- mammalian
- compositions
- methods
- deleted mimetibodies
- mimetibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2318/00—Antibody mimetics or scaffolds
- C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39243102P | 2002-06-28 | 2002-06-28 | |
| US392431P | 2002-06-28 | ||
| PCT/US2003/020347 WO2004002417A2 (fr) | 2002-06-28 | 2003-06-27 | Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1545608A2 EP1545608A2 (fr) | 2005-06-29 |
| EP1545608A4 true EP1545608A4 (fr) | 2006-09-13 |
Family
ID=30000868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03742272A Withdrawn EP1545608A4 (fr) | 2002-06-28 | 2003-06-27 | Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1545608A4 (fr) |
| JP (1) | JP2006504406A (fr) |
| CN (1) | CN1735433A (fr) |
| AU (1) | AU2003280130B2 (fr) |
| CA (1) | CA2490409A1 (fr) |
| WO (1) | WO2004002417A2 (fr) |
Families Citing this family (114)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1783222T3 (da) | 1998-10-23 | 2012-07-09 | Kirin Amgen Inc | Dimere trombopoietiske peptidomimetika, der binder til MPL-receptor og har trombopoietisk aktivitet |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| EP1572079A4 (fr) * | 2002-03-29 | 2006-09-06 | Centocor Inc | Corps mimetiques de cdr de mammifere, compositions, procedes et utilisations |
| EP1575499A2 (fr) * | 2002-06-28 | 2005-09-21 | Centocor, Inc. | Corps mimetiques d'epo de mammifere a deletion ch1, compositions, methodes et utilisations associees |
| WO2005081687A2 (fr) * | 2003-09-30 | 2005-09-09 | Centocor, Inc. | Mimeticorps de noyau-charniere humain, compositions, procedes et applications correspondantes |
| UA89481C2 (uk) * | 2003-09-30 | 2010-02-10 | Центокор, Инк. | Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування |
| JP2008537873A (ja) * | 2004-03-31 | 2008-10-02 | セントカー・インコーポレーテツド | ヒトｇｌｐ−１ミメティボディ、組成物、方法および用途 |
| WO2006036834A2 (fr) | 2004-09-24 | 2006-04-06 | Amgen Inc. | Molecules fc modifiees |
| CA2581505A1 (fr) * | 2004-09-27 | 2006-04-06 | Centocor, Inc. | Corps mimetiques srage, compositions, et methodes d'utilisation |
| KR101255140B1 (ko) * | 2004-10-25 | 2013-04-22 | 얀센 바이오테크 인코포레이티드 | 멜라노코르틴 수용체 결합 모방체, 조성물, 방법 및 용도 |
| CN101389346A (zh) * | 2005-03-28 | 2009-03-18 | 森托科尔公司 | 人glp-1模拟体、组合物、方法和用途 |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| WO2007115148A2 (fr) * | 2006-03-31 | 2007-10-11 | Centocor, Inc. | Mimétiques de l'epo humaine à région centrale à charnière, compositions, procédés et utilisations dans la prévention ou le traitement de pathologies relatives à l'intolérance au glucose ou de l'anémie associée à une néphropathie |
| WO2008028044A2 (fr) | 2006-08-30 | 2008-03-06 | Centocor, Inc. | Marqueurs et procédés pour évaluer et traiter la recto-colite hémorragique et des troubles associés utilisant un panel de 66 gènes |
| WO2008079973A2 (fr) | 2006-12-21 | 2008-07-03 | Centocor, Inc. | Peptides de liaison au récepteur egf et utilisations de ces derniers |
| WO2008079976A2 (fr) * | 2006-12-21 | 2008-07-03 | Centocor, Inc. | Constructions dimères de récepteur egf à haute affinité et utilisations correspondantes |
| US8834920B2 (en) | 2006-12-21 | 2014-09-16 | Alza Corporation | Liposome composition for targeting egfr receptor |
| WO2008092209A1 (fr) * | 2007-02-01 | 2008-08-07 | Arana Therapeutics Limited | Protéine recombinée aux propriétés améliorées |
| CA2701032C (fr) | 2007-09-27 | 2021-01-26 | Amgen Inc. | Formules pharmaceutiques |
| EP3381445B1 (fr) | 2007-11-15 | 2023-10-25 | Amgen Inc. | Formulation aqueuse d'anticorps stabilisée par des antioxydants pour administration parentérale |
| CA2711826C (fr) | 2008-01-25 | 2018-02-27 | Amgen Inc. | Anticorps anti-ferroportine et procedes d'utilisation |
| EP2816059A1 (fr) | 2008-05-01 | 2014-12-24 | Amgen, Inc | Anticorps anti-hepcidine et procédés d'utilisation |
| CN102165315B (zh) | 2008-08-29 | 2014-06-18 | 森托科尔奥索生物科技公司 | 用于使用20基因群组评估及治疗溃疡性结肠炎和相关疾病的标记物和方法 |
| US20120052066A1 (en) | 2008-11-07 | 2012-03-01 | Cesar Calderon | Markers and methods for assessing and treating lupus patients susceptible to photoprovocation |
| EP2349332B1 (fr) | 2008-11-13 | 2019-10-23 | The General Hospital Corporation | Procédés et compositions pour la régulation de l'homéostasie du fer par modulation de la protéine bmp-6 |
| AU2010310457B2 (en) | 2009-10-23 | 2015-07-02 | Amgen Inc. | Vial adapter and system |
| CN102770555B (zh) | 2009-11-17 | 2015-01-28 | 詹森生物科技公司 | 改善的细菌膜蛋白分泌 |
| CA2781019A1 (fr) | 2009-11-17 | 2011-05-26 | Janssen Biotech, Inc. | Presentation de proteines dimeres a liaison disulfure sur phage filamenteux |
| WO2011103164A1 (fr) | 2010-02-18 | 2011-08-25 | Centocor Ortho Biotech Inc. | Homologue de singe d'interféron oméga humain |
| JP5908888B2 (ja) | 2010-04-16 | 2016-04-26 | ヤンセン バイオテツク，インコーポレーテツド | 改変された植物のシステインプロテアーゼ及びその使用 |
| KR102513760B1 (ko) | 2010-06-07 | 2023-03-27 | 암젠 인크 | 약물 전달 장치 |
| EP2621950A4 (fr) | 2010-09-27 | 2015-09-02 | Janssen Biotech Inc | Anticorps se liant au collagène humain de type ii |
| EP2691065B1 (fr) | 2011-03-31 | 2017-03-01 | Amgen Inc. | Adaptateur de flacon et système |
| CA2833748C (fr) | 2011-04-20 | 2019-07-16 | Amgen Inc. | Appareil auto-injecteur |
| EP3335747B1 (fr) | 2011-10-14 | 2021-04-07 | Amgen Inc. | Injecteur et procédé d'assemblage |
| EP3072548B1 (fr) | 2012-11-21 | 2019-03-06 | Amgen, Inc | Dispositif d'administration de médicaments |
| CN111617347B (zh) | 2013-03-15 | 2023-09-29 | 安进公司 | 身体轮廓可调适的自动注射器装置 |
| JP6336564B2 (ja) | 2013-03-15 | 2018-06-06 | アムゲン・インコーポレーテッド | 薬物カセット、自動注入器、および自動注入器システム |
| DK2968503T3 (en) | 2013-03-15 | 2018-12-03 | Intrinsic Lifesciences Llc | ANTI-HEPCIDIN ANTIBODIES AND APPLICATIONS THEREOF |
| US10492990B2 (en) | 2013-03-15 | 2019-12-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
| US20150017162A1 (en) * | 2013-03-15 | 2015-01-15 | Omeros Corporation | Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same |
| EP2976117B1 (fr) | 2013-03-22 | 2020-12-30 | Amgen Inc. | Injecteur et procédé d'assemblage |
| SG11201602876WA (en) | 2013-10-24 | 2016-05-30 | Amgen Inc | Injector and method of assembly |
| WO2015061389A1 (fr) | 2013-10-24 | 2015-04-30 | Amgen Inc. | Système de distribution de médicaments équipé d'un dispositif de commande sensible à la température |
| US10994112B2 (en) | 2014-02-05 | 2021-05-04 | Amgen Inc. | Drug delivery system with electromagnetic field generator |
| SG10201811702TA (en) | 2014-05-07 | 2019-01-30 | Amgen Inc | Autoinjector with shock reducing elements |
| MX387194B (es) | 2014-06-03 | 2025-03-18 | Amgen Inc | Sistemas y metodos para procesar de manera remota datos recolectados por un dispositivo de suministro de farmaco. |
| EP3197915A4 (fr) | 2014-09-22 | 2018-12-19 | Intrinsic Lifesciences LLC | Anticorps anti-hepcidine humanisés et utilisations de ceux-ci |
| EP3943135B1 (fr) | 2014-10-14 | 2025-09-24 | Amgen Inc. | Dispositif d'injection de médicament avec indicateurs visuels et audibles |
| EP3689394A1 (fr) | 2014-12-19 | 2020-08-05 | Amgen Inc. | Dispositif d'administration de médicaments avec bouton mobile ou panneau d'interface utilisateur |
| US10799630B2 (en) | 2014-12-19 | 2020-10-13 | Amgen Inc. | Drug delivery device with proximity sensor |
| ES2748750T3 (es) | 2015-02-17 | 2020-03-17 | Amgen Inc | Dispositivo de administración de fármacos con sujeción asistida por vacío y/o realimentación |
| US11806509B2 (en) | 2015-02-27 | 2023-11-07 | Amgen Inc. | Drug delivery device having a needle guard mechanism with a turnable threshold of resistance to needle guard movement |
| WO2017039786A1 (fr) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Adaptateur d'ensemble de seringue pour une seringue |
| US11351308B2 (en) | 2015-12-09 | 2022-06-07 | Amgen Inc. | Auto-injector with signaling cap |
| US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
| EP3429663B1 (fr) | 2016-03-15 | 2020-07-15 | Amgen Inc. | Réduction de la probabilité de casse du verre dans des dispositifs d'administration de médicament |
| US11541168B2 (en) | 2016-04-29 | 2023-01-03 | Amgen Inc. | Drug delivery device with messaging label |
| US11389588B2 (en) | 2016-05-02 | 2022-07-19 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
| JP7309363B2 (ja) | 2016-05-13 | 2023-07-18 | アムジエン・インコーポレーテツド | バイアル・スリーブ組立体 |
| US11238150B2 (en) | 2016-05-16 | 2022-02-01 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
| WO2017209899A1 (fr) | 2016-06-03 | 2017-12-07 | Amgen Inc. | Appareils et procédés d'essai au choc destinés aux dispositifs d'administration de médicaments |
| EP3478342B1 (fr) | 2016-07-01 | 2025-03-12 | Amgen Inc. | Dispositif d'administration de médicament présentant un risque réduit au minimum de fracture de composant lors d'événements d'impact |
| WO2018034784A1 (fr) | 2016-08-17 | 2018-02-22 | Amgen Inc. | Dispositif d'administration de médicament avec détection de positionnement. |
| US20200261643A1 (en) | 2016-10-25 | 2020-08-20 | Amgen Inc. | On-body injector |
| MX2019008432A (es) | 2017-01-17 | 2019-11-18 | Amgen Inc | Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje. |
| US11752258B2 (en) | 2017-02-17 | 2023-09-12 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
| MX2019009755A (es) | 2017-02-17 | 2019-10-07 | Amgen Inc | Mecanismo de insercion para dispositivo de suministro de farmacos. |
| WO2018165143A1 (fr) | 2017-03-06 | 2018-09-13 | Amgen Inc. | Dispositif d'administration de médicaments doté d'une fonction de prévention d'activation |
| WO2018164829A1 (fr) | 2017-03-07 | 2018-09-13 | Amgen Inc. | Insertion d'aiguille par surpression |
| IL268386B2 (en) | 2017-03-09 | 2023-11-01 | Amgen Inc | Insertion mechanism for a drug delivery device |
| JP2020511499A (ja) | 2017-03-20 | 2020-04-16 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 赤血球生成刺激タンパク質のインビトロでの糖鎖改変のための方法 |
| PL3600491T3 (pl) | 2017-03-28 | 2024-03-04 | Amgen Inc. | Układ i sposób montażu trzonu tłoka i strzykawki |
| WO2018226515A1 (fr) | 2017-06-08 | 2018-12-13 | Amgen Inc. | Ensemble de seringue d'un appareil d'administration de médicament et procédé d'assemblage |
| EP3634546A1 (fr) | 2017-06-08 | 2020-04-15 | Amgen Inc. | Dispositif d'administration de médicament entraîné par couple |
| WO2018236619A1 (fr) | 2017-06-22 | 2018-12-27 | Amgen Inc. | Réduction des impacts/chocs d'activation d'un dispositif |
| JP7475860B2 (ja) | 2017-06-23 | 2024-04-30 | アムジエン・インコーポレーテツド | スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス |
| EP3651832B1 (fr) | 2017-07-14 | 2023-12-13 | Amgen Inc. | Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion |
| US11672733B2 (en) | 2017-07-21 | 2023-06-13 | Amgen Inc. | Gas permeable sealing member for drug container and methods of assembly |
| JP7242562B2 (ja) | 2017-07-25 | 2023-03-20 | アムジエン・インコーポレーテツド | 容器アクセスシステムを有する薬物送達デバイス及び関連する組立方法 |
| JP2020528296A (ja) | 2017-07-25 | 2020-09-24 | アムジエン・インコーポレーテツド | ギヤモジュールを有する薬物送達デバイス及び関連する組立方法 |
| US12318593B2 (en) | 2017-08-09 | 2025-06-03 | Amgen Inc. | Hydraulic-pneumatic pressurized chamber drug delivery system |
| EP3668567A1 (fr) | 2017-08-18 | 2020-06-24 | Amgen Inc. | Injecteur sur-corps avec patch adhésif stérile |
| US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
| US11759565B2 (en) | 2017-10-04 | 2023-09-19 | Amgen Inc. | Flow adapter for drug delivery device |
| EP3691716B1 (fr) | 2017-10-06 | 2023-11-29 | Amgen Inc. | Dispositif d'administration de médicament comprenant un ensemble de verrouillage et procédé d'assemblage associé |
| IL273323B2 (en) | 2017-10-09 | 2024-10-01 | Amgen Inc | Drug delivery device with drive assembly and related assembly method |
| US11826480B2 (en) | 2017-11-03 | 2023-11-28 | Amgen Inc. | Systems and approaches for sterilizing a drug delivery device |
| MA50569A (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc | Ensembles de remplissage-finition et procédés associés |
| MA50553A (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc | Dispositif d'administration de médicament avec détection de positionnement et de débit |
| SG11202002966QA (en) | 2017-11-10 | 2020-05-28 | Amgen Inc | Plungers for drug delivery devices |
| AU2018368340B2 (en) | 2017-11-16 | 2024-03-07 | Amgen Inc. | Door latch mechanism for drug delivery device |
| JP7747438B2 (ja) | 2017-11-16 | 2025-10-01 | アムジエン・インコーポレーテツド | 失速及び終点検出を有するオートインジェクタ |
| US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
| US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
| WO2020023220A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs d'administration de médicament hybrides dotés d'une partie de fixation collante à placer sur la peau et procédé de préparation associé |
| WO2020023336A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs hybrides d'administration de médicament dotés d'une partie de préhension |
| EP3826701A1 (fr) | 2018-07-24 | 2021-06-02 | Amgen Inc. | Dispositifs d'administration pour l'administration de médicaments |
| MX2021000749A (es) | 2018-07-24 | 2021-03-29 | Amgen Inc | Dispositivos de suministro para administrar farmacos. |
| WO2020028009A1 (fr) | 2018-07-31 | 2020-02-06 | Amgen Inc. | Ensemble de trajet de fluide pour dispositif d'administration de médicament |
| JP2022500095A (ja) | 2018-09-24 | 2022-01-04 | アムジエン・インコーポレーテツド | インターベンション投薬システム及び方法 |
| IL281469B2 (en) | 2018-09-28 | 2024-08-01 | Amgen Inc | Muscle wire escapement activation assembly for a drug delivery device |
| EP3860685A1 (fr) | 2018-10-02 | 2021-08-11 | Amgen Inc. | Systèmes d'injection pour administration de médicament avec transmission de force interne |
| US12151089B2 (en) | 2018-10-05 | 2024-11-26 | Amgen Inc. | Drug delivery device having dose indicator |
| MA53912A (fr) | 2018-10-15 | 2022-01-19 | Amgen Inc | Dispositif d'administration de médicament comprenant un mécanisme d'amortissement |
| SG11202101824VA (en) | 2018-10-15 | 2021-03-30 | Amgen Inc | Platform assembly process for drug delivery device |
| EP3873566B1 (fr) | 2018-11-01 | 2024-11-27 | Amgen Inc. | Dispositifs d'administration de médicament avec rétraction partielle de l'organe d'administration de médicament |
| AU2019370159B2 (en) | 2018-11-01 | 2025-05-29 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
| TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
| US20220160972A1 (en) | 2019-04-24 | 2022-05-26 | Amgen Inc. | Syringe sterilization verification assemblies and methods |
| JP7608439B2 (ja) | 2019-08-23 | 2025-01-06 | アムジエン・インコーポレーテツド | 構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法 |
| KR102883648B1 (ko) * | 2020-09-16 | 2025-11-10 | 한미약품 주식회사 | 폴리에틸렌글리콜 유도체, 이를 포함하는 조성물 및 이를 이용한 생리활성 폴리펩타이드 결합체의 제조 방법 |
| US20240208680A1 (en) | 2021-05-21 | 2024-06-27 | Amgen Inc. | Method of optimizing a filling recipe for a drug container |
| EP4612312A1 (fr) | 2022-11-02 | 2025-09-10 | F. Hoffmann-La Roche AG | Procédé de production de compositions de glycoprotéines |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5608035A (en) * | 1994-02-02 | 1997-03-04 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| WO2000024782A2 (fr) * | 1998-10-23 | 2000-05-04 | Amgen Inc. | Peptides modifies utilises comme agents therapeutiques |
| US20020012989A1 (en) * | 1993-02-01 | 2002-01-31 | Bristol-Myers Squibb Company | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| WO2002046227A2 (fr) * | 2000-12-07 | 2002-06-13 | Eli Lilly And Company | Proteines hybrides glp-1 |
| WO2002046238A2 (fr) * | 2000-12-05 | 2002-06-13 | Alexion Pharmaceuticals, Inc. | Anticorps conçus de maniere rationnelle |
| WO2003084477A2 (fr) * | 2002-03-29 | 2003-10-16 | Centocor, Inc. | Corps mimetiques de cdr de mammifere, compositions, procedes et utilisations |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4309989A (en) | 1976-02-09 | 1982-01-12 | The Curators Of The University Of Missouri | Topical application of medication by ultrasound with coupling agent |
| FR2374910A1 (fr) | 1976-10-23 | 1978-07-21 | Choay Sa | Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
| US5149636A (en) | 1982-03-15 | 1992-09-22 | Trustees Of Columbia University In The City Of New York | Method for introducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products |
| US5169762A (en) | 1983-03-03 | 1992-12-08 | Genentech, Inc. | Human nerve growth factor by recombinant technology |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| SE448277B (sv) | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
| US4740587A (en) | 1985-07-18 | 1988-04-26 | The Salk Institute For Biological Studies | Inhibin and method of purifying same |
| US4721672A (en) | 1985-08-28 | 1988-01-26 | President And Fellows Of Harvard College | CDNA and gene for human angiogenin (angiogenesis factor) and methods of expression |
| US4870163A (en) | 1985-08-29 | 1989-09-26 | New York Blood Center, Inc. | Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4737578A (en) | 1986-02-10 | 1988-04-12 | The Salk Institute For Biological Studies | Human inhibin |
| SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
| US4767402A (en) | 1986-07-08 | 1988-08-30 | Massachusetts Institute Of Technology | Ultrasound enhancement of transdermal drug delivery |
| US4925673A (en) | 1986-08-18 | 1990-05-15 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| DE3631229A1 (de) | 1986-09-13 | 1988-03-24 | Basf Ag | Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung |
| EP0832981A1 (fr) | 1987-02-17 | 1998-04-01 | Pharming B.V. | Séquences d'ADN pour diriger des protéines vers les glandes mammaires, afin d'être secrétées efficacement |
| JP2647427B2 (ja) | 1987-04-24 | 1997-08-27 | 帝人株式会社 | 被検者の病態の判定のための検出方法、モノクロ−ナル抗体および検出キット |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US4956288A (en) | 1988-04-22 | 1990-09-11 | Biogen, Inc. | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA |
| US5231166A (en) | 1988-10-25 | 1993-07-27 | Takeda Chemical Industries, Ltd. | Endothelin |
| US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| US5266491A (en) | 1989-03-14 | 1993-11-30 | Mochida Pharmaceutical Co., Ltd. | DNA fragment and expression plasmid containing the DNA fragment |
| JP3443119B2 (ja) | 1989-08-07 | 2003-09-02 | ペプテック リミテッド | 腫瘍壊死因子結合リガンド |
| US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
| US5210026A (en) | 1990-08-20 | 1993-05-11 | American Cyanamid Company | Human mk gene and method of expression |
| GB9022648D0 (en) | 1990-10-18 | 1990-11-28 | Charing Cross Sunley Research | Polypeptide and its use |
| US5268465A (en) | 1991-01-18 | 1993-12-07 | The Johns Hopkins University | Purification and molecular cloning of nitric oxide synthase |
| US5404871A (en) | 1991-03-05 | 1995-04-11 | Aradigm | Delivery of aerosol medications for inspiration |
| ES2199935T3 (es) | 1991-03-15 | 2004-03-01 | Amgen Inc. | Pegilacion de polipeptidos. |
| US5834229A (en) | 1991-05-24 | 1998-11-10 | Genentech, Inc. | Nucleic acids vectors and host cells encoding and expressing heregulin 2-α |
| IL101943A0 (en) | 1991-05-24 | 1992-12-30 | Genentech Inc | Structure,production and use of heregulin |
| US5637481A (en) * | 1993-02-01 | 1997-06-10 | Bristol-Myers Squibb Company | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| CA2112674C (fr) | 1991-07-02 | 2005-10-04 | John S. Patton | Methode et instrument pour la delivrance de medicaments en aerosol |
| US5976835A (en) | 1992-03-19 | 1999-11-02 | The Rockefeller University | Nucleic acids encoding receptor recognition factor Stat1α and Stat1β, and methods of use thereof |
| US5447851B1 (en) | 1992-04-02 | 1999-07-06 | Univ Texas System Board Of | Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells |
| US5315000A (en) | 1992-05-14 | 1994-05-24 | Children's Hospital Medical Center | Gene encoding for a L5/3 growth factor and its CDNA |
| AU4829593A (en) | 1992-09-23 | 1994-04-12 | Fisons Plc | Inhalation device |
| PL172758B1 (pl) | 1992-10-19 | 1997-11-28 | Dura Pharma Inc | Inhalator do proszków suchych PL PL PL PL PL PL PL |
| US5643252A (en) | 1992-10-28 | 1997-07-01 | Venisect, Inc. | Laser perforator |
| US6143289A (en) | 1992-12-09 | 2000-11-07 | Indiana University Foundation | Compositions of myeloid-cell-suppressive chemokines |
| US5849695A (en) | 1993-01-13 | 1998-12-15 | The Regents Of The University Of California | Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals |
| AU5883694A (en) | 1993-01-19 | 1994-08-15 | Glaxo Group Limited | Device |
| PL310327A1 (en) | 1993-02-12 | 1995-12-11 | Univ Leland Stanford Junior | Adjustable transcription of target genes and other biological processes |
| US5514670A (en) | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
| US5814599A (en) | 1995-08-04 | 1998-09-29 | Massachusetts Insitiute Of Technology | Transdermal delivery of encapsulated drugs |
| US5773569A (en) | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
| US5981478A (en) | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
| US6190655B1 (en) | 1993-12-03 | 2001-02-20 | Immunex Corporation | Methods of using Flt-3 ligand for exogenous gene transfer |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US5786331A (en) | 1994-02-02 | 1998-07-28 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5880096A (en) | 1994-02-02 | 1999-03-09 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US6174995B1 (en) | 1994-08-23 | 2001-01-16 | Haodong Li | Human chemokines, CKβ4 and CKβ10/MCP-4 |
| WO1996015152A1 (fr) | 1994-11-11 | 1996-05-23 | International Reagents Corporation | Anticorps monoclonal antiannexine-v, procede pour produire cet anticorps, et utilisation de cet anticorps |
| US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
| US5767078A (en) | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
| US5817750A (en) | 1995-08-28 | 1998-10-06 | La Jolla Cancer Research Foundation | Structural mimics of RGD-binding sites |
| US6284535B1 (en) | 1995-09-07 | 2001-09-04 | The Trustees Of Columbia University In The City Of New York | Splice variants of the heregulin gene, nARIA and uses thereof |
| GB9526100D0 (en) | 1995-12-20 | 1996-02-21 | Intersurgical Ltd | Nebulizer |
| US6065472A (en) | 1996-01-03 | 2000-05-23 | Glaxo Wellcome Inc. | Multidose powder inhalation device |
| US5700774A (en) | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
| IL118003A0 (en) | 1996-04-23 | 1996-08-04 | Yeda Res & Dev | Novel vip fragments and pharmaceutical compositions comprising them |
| US6271347B1 (en) | 1996-04-26 | 2001-08-07 | Merck & Co., Inc. | Eosinophil eotaxin receptor |
| CA2257108A1 (fr) | 1996-06-07 | 1997-12-11 | Takeda Chemical Industries, Ltd. | Peptide, procede de production et mode d'utilisation correspondants |
| DK0857718T3 (da) | 1996-06-10 | 2002-12-16 | Sucampo Ag | Endothelinantagonist |
| US6126939A (en) | 1996-09-03 | 2000-10-03 | Yeda Research And Development Co. Ltd. | Anti-inflammatory dipeptide and pharmaceutical composition thereof |
| WO1998009940A1 (fr) | 1996-09-04 | 1998-03-12 | Warner-Lambert Company | Acides biphenyl-butyriques et leurs derives, utilises comme inhibiteurs des metalloproteases de matrice |
| CA2218456A1 (fr) | 1996-10-15 | 1998-04-15 | The Rockefeller University | Proteines stat purifiees et methodes pour les purifier |
| JP4671372B2 (ja) | 1996-11-15 | 2011-04-13 | ジェネンテック， インコーポレイテッド | ニューロトロフィンの精製 |
| EP0944311B1 (fr) | 1996-11-19 | 2006-03-01 | Georgetown University | Methode pour inhibition d'HEREGULINE ET son receptor et utilisation pour l'inhibition des cellules cancereux |
| US5948892A (en) | 1996-12-16 | 1999-09-07 | Amgen Inc. | Analogs of macrophage stimulating protein |
| US5879681A (en) | 1997-02-07 | 1999-03-09 | Emisphere Technolgies Inc. | Compounds and compositions for delivering active agents |
| US6136558A (en) | 1997-02-10 | 2000-10-24 | Genentech, Inc. | Heregulin variants |
| US5921447A (en) | 1997-02-13 | 1999-07-13 | Glaxo Wellcome Inc. | Flow-through metered aerosol dispensing apparatus and method of use thereof |
| IT1292017B1 (it) | 1997-05-28 | 1999-01-25 | Dompe Spa | Composizioni farmaceutiche contenenti la proteina stimolante i macrofagi per il trattamento di patologie del sistema nervoso |
| IL120943A (en) | 1997-05-29 | 2004-03-28 | Univ Ben Gurion | A system for administering drugs through the skin |
| US6265535B1 (en) | 1997-05-30 | 2001-07-24 | The Trustees Of The University Of Pennsylvania | Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses |
| AR016551A1 (es) | 1997-07-30 | 2001-07-25 | Smithkline Beecham Corp | Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos |
| US6180084B1 (en) * | 1998-08-25 | 2001-01-30 | The Burnham Institute | NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same |
-
2003
- 2003-06-27 JP JP2004517981A patent/JP2006504406A/ja active Pending
- 2003-06-27 AU AU2003280130A patent/AU2003280130B2/en not_active Ceased
- 2003-06-27 CA CA002490409A patent/CA2490409A1/fr not_active Abandoned
- 2003-06-27 WO PCT/US2003/020347 patent/WO2004002417A2/fr not_active Ceased
- 2003-06-27 EP EP03742272A patent/EP1545608A4/fr not_active Withdrawn
- 2003-06-30 CN CNA038201100A patent/CN1735433A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020012989A1 (en) * | 1993-02-01 | 2002-01-31 | Bristol-Myers Squibb Company | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| US5608035A (en) * | 1994-02-02 | 1997-03-04 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| WO2000024782A2 (fr) * | 1998-10-23 | 2000-05-04 | Amgen Inc. | Peptides modifies utilises comme agents therapeutiques |
| WO2002046238A2 (fr) * | 2000-12-05 | 2002-06-13 | Alexion Pharmaceuticals, Inc. | Anticorps conçus de maniere rationnelle |
| WO2002046227A2 (fr) * | 2000-12-07 | 2002-06-13 | Eli Lilly And Company | Proteines hybrides glp-1 |
| WO2003084477A2 (fr) * | 2002-03-29 | 2003-10-16 | Centocor, Inc. | Corps mimetiques de cdr de mammifere, compositions, procedes et utilisations |
Non-Patent Citations (14)
| Title |
|---|
| BES CEDRIC ET AL: "Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR-H1-derived peptide CB1", FEBS LETTERS, vol. 508, no. 1, 9 November 2001 (2001-11-09), pages 67 - 74, XP004322279, ISSN: 0014-5793 * |
| CASARES SOFIA ET AL: "Foreign peptides expressed in engineered chimeric self molecules", BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS INTERCEPT LTD. {A}, P. O. BOX 716, ANDOVER SP10 1YG, ENGLAND SERIES : BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS (ISSN 0264-8725), 1998, pages 159 - 198, XP009069478, ISSN: 1-898298-54-8 * |
| HAYDEN M S ET AL: "Antibody engineering", CURRENT OPINION IN IMMUNOLOGY, CURRENT BIOLOGY LTD, vol. 9, no. 2, April 1997 (1997-04-01), pages 201 - 212, XP004327252, ISSN: 0952-7915 * |
| HAYDEN M S ET AL: "SINGLE-CHAIN MONO- AND BISPECIFIC ANTIBODY DERIVATIVES WITH NOVEL BIOLOGICAL PROPERTIES AND ANTITUMOUR ACTIVITY FROM A COS CELL TRANSIENT EXPRESSION SYSTEM", THERAPEUTIC IMMUNOLOGY, BLACKWELL SCIENTIFIC PUBL. LONDON, GB, vol. 1, no. 1, January 1994 (1994-01-01), pages 3 - 15, XP009023719, ISSN: 0967-0149 * |
| HUFTON-SE ET AL: "Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 475, no. 3, 23 June 2000 (2000-06-23), pages 225 - 231, XP004337267, ISSN: 0014-5793 * |
| IGARASHI T ET AL: "Structure of a mouse immunoglobulin G that lacks the entire CH1 domain: protein sequencing and small-angle X-ray scattering studies.", BIOCHEMISTRY. 19 JUN 1990, vol. 29, no. 24, 19 June 1990 (1990-06-19), pages 5727 - 5733, XP002389674, ISSN: 0006-2960 * |
| JACOBIN MARIE-JOSEE ET AL: "Human IgG monoclonal anti-alphaIIbbeta3-binding fragments derived from immunized donors using phage display.", JOURNAL OF IMMUNOLOGY, vol. 168, no. 4, 15 February 2002 (2002-02-15), pages 2035 - 2045, XP002389673, ISSN: 0022-1767 * |
| LAMBERT MIREILLE ET AL: "Immobilized dimers of N-cadherin-Fc chimera mimic cadherin-mediated cell contact formation: Contribution of both outside-in and inside-out signals", JOURNAL OF CELL SCIENCE, vol. 113, no. 12, June 2000 (2000-06-01), pages 2207 - 2219, XP002389675, ISSN: 0021-9533 * |
| LIVNAH O ET AL: "FUNCTIONAL MIMICRY OF A PROTEIN HORMONE BY A PEPTIDE AGONIST: THE EPO RECEPTOR COMPLEX AT 2.8 AA", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, vol. 273, 26 July 1996 (1996-07-26), pages 464 - 471, XP002021035, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.273.5274.464 * |
| MONNET CELINE ET AL: "Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 6, 5 February 1999 (1999-02-05), pages 3789 - 3796, XP002283342, ISSN: 0021-9258 * |
| SAGOT MARIE-ASTRID ET AL: "A monoclonal antibody directed against the neurokinin-1 receptor contains a peptide sequence with similar hydropathy and functional properties to substance P, the natural ligand for the receptor", MOLECULAR IMMUNOLOGY, vol. 37, no. 8, June 2000 (2000-06-01), pages 423 - 433, XP002389672, ISSN: 0161-5890 * |
| See also references of WO2004002417A2 * |
| WELLS J A: "HORMONE MIMICRY", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, vol. 273, 26 July 1996 (1996-07-26), pages 449/450, XP000999487, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.273.5274.449 * |
| WRIGHTON N C ET AL: "Small peptides as potent mimetics of the protein hormone erythropoietin", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, no. 273, 1 July 1996 (1996-07-01), pages 458 - 463, XP002074894, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.273.5274.458 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1545608A2 (fr) | 2005-06-29 |
| AU2003280130B2 (en) | 2009-06-11 |
| AU2003280130A1 (en) | 2004-01-19 |
| WO2004002417A3 (fr) | 2004-11-04 |
| CA2490409A1 (fr) | 2004-01-08 |
| CN1735433A (zh) | 2006-02-15 |
| JP2006504406A (ja) | 2006-02-09 |
| WO2004002417A2 (fr) | 2004-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1545608A4 (fr) | Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations | |
| WO2004002424A8 (fr) | Corps mimetiques d'epo de mammifere a deletion ch1, compositions, methodes et utilisations associees | |
| AU2003222069A8 (en) | Mammalian cdr mimetibodies, compositions, methods and uses | |
| EP1572079A3 (fr) | Corps mimetiques de cdr de mammifere, compositions, procedes et utilisations | |
| EP1542699A4 (fr) | Composes, compositions et methodes d'utilisation de ces derniers | |
| AU2003251858A1 (en) | Microbubble compositions, and methods for preparing and using same | |
| AU2003262747A8 (en) | Compounds, compositions, and methods | |
| EP1503993A4 (fr) | Composes, compositions et procedes | |
| AU2003236527A8 (en) | Compounds, compositions, and methods | |
| AU2003265242A8 (en) | Compounds, compositions, and methods | |
| AU2003270015A8 (en) | Compounds, compositions, and methods | |
| AU2003299612A8 (en) | Compounds, compositions and methods | |
| IL164581A0 (en) | Compounds, compositions and methods | |
| AU2003286474A8 (en) | Compositions, solutions, and methods used for transplantation | |
| AU2003277079A8 (en) | Compounds, compositions, and methods | |
| AU2003290507A8 (en) | Compounds, compositions and methods | |
| IL167936A0 (en) | Compounds, compositions,and methods | |
| EP1711527A4 (fr) | Anticorps specifiques de hla-dr, compositions et methodes associees | |
| AU2003237332A8 (en) | Anti-relp fusion antibodies, compositions, methods and uses | |
| AU2003293765A1 (en) | Novel skin lightening agents, compositions and methods | |
| AU2003267169A8 (en) | Compounds, compositions and methods | |
| AU2003300031A8 (en) | Compounds, compositions, and methods | |
| AU2002952442A0 (en) | Probiotic Compositions, Combinations and Related Methods | |
| HK1074624A (en) | Compounds, compositions, and methods | |
| HK1074572A (en) | Compounds, compositions, and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20050127 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20060810 |
|
| 17Q | First examination report despatched |
Effective date: 20080225 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CENTOCOR ORTHO BIOTECH INC. |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: JANSSEN BIOTECH, INC. |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20120508 |